Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
about
H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccinesEvaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMPH5N1 viruses and vaccinesBroad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccineCross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particleMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsH5N1 vaccines in humansPreclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineCommentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countriesReceptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferretsNonreplicating influenza A virus vaccines confer broad protection against lethal challengeImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primatesInfluenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferretsEmergence and pandemic potential of swine-origin H1N1 influenza virusA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsThe Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.Development of live attenuated influenza vaccines against pandemic influenza strains.Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness.Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets.Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetProgress and shortcomings in European national strategic plans for pandemic influenza.Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccineCloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells.Vaccines for a potential influenza pandemic.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.Avian influenza virus (H5N1): a threat to human health.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesNovel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.Pandemic H5N1 influenza vaccine development: an update.A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines.Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
P2860
Q21090076-B8FEFA43-80C7-4354-89D7-0F73916628FBQ21090975-C895712C-8D06-4789-AC83-660743E79D81Q21131612-2E757460-AA1F-4079-9011-6436D821AB63Q21144344-9D81BABD-7331-4298-BFB2-F33FB8B67D30Q21562299-49634889-151D-4E3E-BF75-2B47EE06A1BFQ24648051-681556C0-0F3A-4200-9CD5-099AA4415362Q27000896-450EB8D2-BBE5-4B69-AB73-03A39FB0ACBCQ27347652-069E8E75-9E5A-47CE-9D9E-5F071159D173Q28242054-0BE00270-FCD8-4B9A-A596-D3237E10C505Q28390287-F3FB5E98-969F-43E2-9C0D-C5B30A971D9FQ28392109-27CCE339-E9D3-48BF-A54A-8273508648C5Q28475369-F41D2AD0-52B9-4F21-98FA-804F82E77D3AQ28742787-54415302-355A-46AC-8D41-5457908115DDQ29619003-4D100B78-2372-408C-8459-084B91230BB7Q30204020-96CEB61C-2928-4D7A-9F1E-F3DADA2F665AQ30205724-83562421-6470-4E91-8674-5245DEB22A25Q30209998-3F02E597-5255-4804-82A2-4582976D993EQ30224923-4378915B-1D21-40ED-A4B9-E3289E192242Q30227151-612B1C11-114A-4BC4-9A16-22E0F556D746Q30227194-0145DD7E-59A0-4820-BACE-DB98FF4F05D6Q30229094-23218F51-83A3-47A7-9A7B-3CE9CF0EBD30Q30229190-2DBCCC07-379E-4B30-98CE-A9877AA51B9BQ30229314-50961920-9FC7-413E-8DB7-11B21954F832Q30229470-4429392A-3ACD-43C4-910B-0001E80B4FE0Q30359896-404D4252-C899-4303-8309-7714CC2AD886Q30360436-911A03A5-6AC0-4918-A90F-E25FF11D9000Q30360869-51D5DC41-1272-4FCE-BABD-AE04FC712CFBQ30361041-9B14DB11-B2BB-4594-9094-2BB73D5A7A2EQ30361939-C5C41B2B-B4AA-42FE-B33A-ACCCC4B72C8AQ30362332-278A38AE-2391-4C6D-A7ED-AB0B2867E716Q30362794-4D0EEA96-E0B9-403F-90C4-274E3EA99BD0Q30365696-F3B414CC-5E76-4E5E-B0AC-8E98EDEE05FEQ30366819-E7C31EF1-323C-4539-A09D-54E6D8F97525Q30368132-59375925-6EF5-4641-9D6B-CFE841CD551CQ30370147-743DC3F8-F0CB-4A58-A923-650E444E20AEQ30370303-7A660A32-1760-44F6-9F4C-7B6BBB056B95Q30371054-BE16068B-3034-4419-BB13-B21904CDF9DFQ30372159-CC441310-6F4B-451D-B2A6-66F85628C711Q30372964-337F5BAF-8DB7-49B4-A0FD-FD8095AF1945Q30373843-173E5B94-CEDD-4256-8993-45575A276CD3
P2860
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Live, attenuated influenza A H ...... protection in mice and ferrets
@ast
Live, attenuated influenza A H ...... protection in mice and ferrets
@en
Live, attenuated influenza A H ...... protection in mice and ferrets
@en-gb
Live, attenuated influenza A H ...... protection in mice and ferrets
@nl
type
label
Live, attenuated influenza A H ...... protection in mice and ferrets
@ast
Live, attenuated influenza A H ...... protection in mice and ferrets
@en
Live, attenuated influenza A H ...... protection in mice and ferrets
@en-gb
Live, attenuated influenza A H ...... protection in mice and ferrets
@nl
altLabel
Live, Attenuated Influenza A H ...... Protection in Mice and Ferrets
@en
prefLabel
Live, attenuated influenza A H ...... protection in mice and ferrets
@ast
Live, attenuated influenza A H ...... protection in mice and ferrets
@en
Live, attenuated influenza A H ...... protection in mice and ferrets
@en-gb
Live, attenuated influenza A H ...... protection in mice and ferrets
@nl
P2093
P2860
P50
P3181
P1433
P1476
Live, attenuated influenza A H ...... protection in mice and ferrets
@en
P2093
Amorsolo L Suguitan
Brian Murphy
Catherine J Luke
Josephine McAuliffe
Kimberly L Mills
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030360
P407
P577
2006-09-01T00:00:00Z